5d 1m 3m 1y 5y 10y
There are no Transcripts on FATE.
Fate Therapeutics Commences Phase 2 Clinical Trial of PROHEMA(R) for the Treatment of Hematologic MalignanciesGlobeNewswire (Wed, 7:01AM)
GlobeNewswire (Feb 28, 2014)
GlobeNewswire (Feb 27, 2014)
FATE vs. ETF Alternatives